BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14747023)

  • 1. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosomiasis: challenges for control, treatment and drug resistance.
    Fenwick A; Webster JP
    Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for the control of parasitic diseases: current status and development in schistosomiasis.
    Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH
    Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962
    [No Abstract]   [Full Text] [Related]  

  • 5. Praziquantel.
    Cioli D; Pica-Mattoccia L
    Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study progress on the mode of action of praziquantel against schistosomes].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W; Wang W; Huang YX
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.
    Doenhoff MJ; Hagan P; Cioli D; Southgate V; Pica-Mattoccia L; Botros S; Coles G; Tchuem Tchuenté LA; Mbaye A; Engels D
    Parasitology; 2009 Nov; 136(13):1825-35. PubMed ID: 19281637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosomiasis--a century searching for chemotherapeutic drugs.
    Ribeiro-dos-Santos G; Verjovski-Almeida S; Leite LC
    Parasitol Res; 2006 Oct; 99(5):505-21. PubMed ID: 16636847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Something old, something new: is praziquantel enough for schistosomiasis control?
    Secor WE; Montgomery SP
    Future Med Chem; 2015; 7(6):681-4. PubMed ID: 25996059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel].
    Guo J; Guo JG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 17. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites.
    Utzinger J; Xiao S; Keiser J; Chen M; Zheng J; Tanner M
    Curr Med Chem; 2001 Dec; 8(15):1841-60. PubMed ID: 11772354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
    Bergquist R; Utzinger J; Keiser J
    Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better understanding of anti-schistosomal strategies through microarray analysis.
    Gobert GN
    Infect Disord Drug Targets; 2010 Aug; 10(4):251-7. PubMed ID: 20429867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.